Hester acquires technology from ICAR – NIHSAD to develop Low Pathogenic Avian Influenza (H9N2 strain) Inactivated Vaccine for poultry Read more
Hester signs deal ICAR – IVRI for technology to develop Brucella Abortus S19 Delta per Vaccine Read more